St. Jude's (STJ) LEADLESS II Study Solid with No Hangups - Evercore
Tweet Send to a Friend
Evercore ISI affirms St. Jude Medical (NYSE: STJ) with a Hold rating and $80 price target after STJ announced primary ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
